Skip to main content

SOLIGENIX INC

For the period ended Dec 31, 2023. Filed Mar 15, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 15, 2024

SNGX$0.34+0.5%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Signatures

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

​​​
​SOLIGENIX, INC.
​By:/s/ Christopher J. Schaber
​​Christopher J. Schaber, PhD
​​Chief Executive Officer and President
​​​
Date: March 15, 2024​​

In accordance with the Exchange Act, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated and on the dates indicated.

​​​​​
NameCapacityDate
​​​​​
​​Chairman of the Board, Chief Executive Officer​​
/s/ Christopher J. Schaber​and​March 15, 2024
Christopher J. Schaber, PhD​President (principal executive officer)​​
​​​​​
/s/ Gregg A. Lapointe​Director​March 15, 2024
Gregg A. Lapointe, CPA​​​​
​​​​​
/s/ Diane L. Parks​Director​March 15, 2024
Diane L. Parks, MBA​​​​
​​​​​
/s/ Robert J. Rubin​Director​March 15, 2024
Robert J. Rubin, MD​​​​
​​​​​
/s/ Jerome B. Zeldis​Director​March 15, 2024
Jerome B. Zeldis, MD, PhD​​​​
​​​​​
/s/ Jonathan Guarino​Chief Financial Officer, Senior Vice President, and​March 15, 2024
Jonathan Guarino, CPA, CGMA​Corporate Secretary (principal accounting officer)​​

SOLIGENIX, INC. AND SUBSIDIARIES

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.